A model for plasma volume changes during short duration spaceflight

It is well established that plasma volume decreases during spaceflight and simulated weightlessness (bedrest). The decrement in plasma volume is thought to contribute to the orthostatic intolerance that has been observed in some crew members following spaceflight. To date, no studies have evaluated the effectiveness of fluid countermeasures of varying osmolality in the restoration of plasma volume and orthostatic tolerance in a controlled study. The overall objectives of this project were to: (1) provide a model that would rapidly and safely produce a fluid loss comparable to that which occurs during short duration spaceflight; and (2) design a study that would determine the optimal drink solution to restore orthostatic tolerance and describe the mechanism(s) whereby orthostatic tolerance is restored. In summary, Lasix can be used as a way of simulating the plasma volume changes that occur during short duration spaceflight. The total loss of plasma is comparable to spaceflight. Lasix is fast acting, and has relatively few side effects. The present design for evaluating the optimal fluid countermeasures will have important implications in restoring orthostatic tolerance and function in the latter stages of spaceflight when it is essential for safe operation of the spacecraft.